Back to Search
Start Over
Additional Detailed Analyses From Phase 2 Study 201 of Lecanemab Published as Three Papers in Peer-Reviewed Journals
- Source :
- Thomson Reuters ONE. March 30, 2023
- Publication Year :
- 2023
-
Abstract
- (GLOBE NEWSWIRE via COMTEX) -- TOKYO and CAMBRIDGE, Mass., March 30, 2023 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, 'Eisai') and Biogen Inc. (Nasdaq: BIIB, Corporate [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Thomson Reuters ONE
- Publication Type :
- News
- Accession number :
- edsgcl.743639518